|
PSIP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.34450001027164E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.46779999266045E-09 |
| Normal-vs-Stage2 |
2.21980000003619E-06 |
| Normal-vs-Stage3 |
2.778300E-03 |
| Normal-vs-Stage4 |
6.978400E-02 |
| Stage1-vs-Stage2 |
8.982200E-01 |
| Stage1-vs-Stage3 |
3.183800E-01 |
| Stage1-vs-Stage4 |
4.223600E-01 |
| Stage2-vs-Stage3 |
3.730400E-01 |
| Stage2-vs-Stage4 |
3.670000E-01 |
| Stage3-vs-Stage4 |
8.970800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.03189998160269E-09 |
| Normal-vs-AfricanAmerican |
4.3347999999499E-06 |
| Normal-vs-Asian |
1.484520E-03 |
| Caucasian-vs-AfricanAmerican |
4.705000E-01 |
| Caucasian-vs-Asian |
7.537000E-01 |
| AfricanAmerican-vs-Asian |
5.589800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.48769926669956E-11 |
| Normal-vs-Female |
9.000300E-03 |
| Male-vs-Female |
1.384740E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.81248999999717E-05 |
| Normal-vs-Extreme_Weight |
1.49610002164735E-09 |
| Normal-vs-Obese |
5.83519999999282E-05 |
| Normal-vs-Extreme_Obese |
7.36229999964699E-07 |
| Normal_Weight-vs-Extreme_Weight |
3.983600E-01 |
| Normal_Weight-vs-Obese |
4.891000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.411600E-01 |
| Extreme_Weight-vs-Obese |
8.332000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.793200E-01 |
| Obese-vs-Extreme_Obese |
1.162390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.574600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.63060000000415E-05 |
| Normal-vs-Age(61-80Yrs) |
1.15110143639185E-11 |
| Normal-vs-Age(81-100Yrs) |
1.74363999999594E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.271200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.717500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.752000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.337200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.974780E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.956800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.8268000445687E-09 |
| Normal-VS-Type2 PRCC |
3.70310448971622E-11 |
| Normal-VS-KIRP CIMP |
2.525800E-01 |
| Normal-VS-Unclassified PRCC |
1.917810E-03 |
| Type1 PRCC-VS-Type2 PRCC |
8.286300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.74216999999643E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
3.140400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.00659999966591E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
4.315600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.639100E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.95990010279468E-10 |
| Normal-vs-N1 |
4.224100E-02 |
| Normal-vs-N2 |
3.481900E-03 |
| N0-vs-N1 |
1.283860E-02 |
| N0-vs-N2 |
7.575000E-01 |
| N1-vs-N2 |
4.298400E-01 |
|
|
